Cytomedix (GTF) Forms Scientific Advisory Board
Cytomedix, Inc. (AMEX: GTF) announced that they have formed a Scientific Advisory Board (SAB).
The initial six-member SAB, which includes physicians, clinicians and medical researchers, will provide counsel to Cytomedix management on a range of scientific, clinical, product development and commercialization topics.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The initial six-member SAB, which includes physicians, clinicians and medical researchers, will provide counsel to Cytomedix management on a range of scientific, clinical, product development and commercialization topics.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Cytokinetics (CYTK) Opens Second Cohort for ATOMIC-AHF Phase IIb
- Medivation (MDVN) Submits NDA for Enzalutamide to U.S. FDA
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
